Full name
EUROPHARMA RACHTAN SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
18.1 - Printing and service activities related to printing
58 - Publishing activities
63 - Information service activities
68 - Real estate activities
71.2 - Technical testing and analysis
73.1 - Advertising
73.20.Z - Market research and public opinion polling
77 - Rental and leasing activities
79 - Travel agency, tour operator and other reservation service and related activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | -0,1 | 0,5 | 989,8 |
Gross profit (loss) | 0,1 | -0,1 | 0,3 | 443,5 |
EBITDA | 0,1 | -0 | 0,3 | 798 |
Short time liabilities | 0,1 | 0,6 | 1 | 62,5 |
Other operating costs | 0 | 0 | 0,2 | 2093,2 |
Equity capital | 0,8 | 0,7 | 0,9 | 32,9 |
Operating profit (EBIT) | 0,1 | -0,1 | 0,3 | 536,5 |
Assets | 0,8 | 1,3 | 1,9 | 46,4 |
Net profit (loss) | 0 | -0,1 | 0,2 | 392 |
Cash | 0,2 | 0,4 | 0,3 | -15,9 |
Net income from sale | 0,3 | 5,6 | 6,9 | 21,8 |
Liabilities and provisions for liabilities | 0,1 | 0,6 | 1 | 62,5 |
Working assets | 0,2 | 0,7 | 1 | 46,6 |
Other income costs | 0 | 0 | 0 | 582 885,7 |
Depreciation | 0 | 0 | 0 | -38 |
% | % | % | p.p. | |
Profitability of capital | 0 | -11,3 | 24,8 | 36,1 |
Equity capital to total assets | 93,6 | 54,6 | 49,5 | -5,1 |
Gross profit margin | 41,2 | -1,4 | 4 | 5,4 |
EBITDA Margin | 45,7 | -0,8 | 4,6 | 5,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 61 | 38 | 51 | 13 |
Current financial liquidity indicator | 3.888136625289917 | 1.1050366163253784 | 0.996496319770813 | -0,1 |
Net dept to EBITDA | -1.3067634105682373 | 9.083995819091797 | -1.0918898582458496 | -10,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane